We are live on ! Find out more
SIC

Samalin Investment Counsel Portfolio holdings

AUM $320M
1-Year Est. Return 20.87%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+20.87%
3 Year Est. Return
+62.81%
5 Year Est. Return
+65.92%
10 Year Est. Return
AUM
$198M
AUM Growth
+$23.8M
Cap. Flow
+$9.01M
Cap. Flow %
4.55%
Top 10 Hldgs %
19.12%
Holding
284
New
27
Increased
128
Reduced
108
Closed
12
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFP
101
Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP
$405M
$618K 0.31%
34,840
+11,673
+50% +$197K
BKCC
102
DELISTED
BlackRock Capital Investment Corporation
BKCC
$607K 0.31%
156,844
+4,107
+3% +$14.9K
BGR icon
103
BlackRock Energy and Resources Trust
BGR
$449M
$604K 0.31%
48,539
+13,263
+38% +$167K
PEP icon
104
PepsiCo
PEP
$186B
$588K 0.3%
3,461
+44
+1% +$7.3K
THW
105
abrdn World Healthcare Fund
THW
$540M
$584K 0.29%
50,010
+17,206
+52% +$194K
MPT
106
Medical Properties Trust
MPT
$2.17B
$579K 0.29%
117,989
+50,199
+74% +$246K
THQ
107
abrdn Healthcare Opportunities Fund
THQ
$784M
$577K 0.29%
31,851
+8,957
+39% +$152K
MGPI icon
108
MGP Ingredients
MGPI
$316M
$573K 0.29%
+5,819
New +$559K
MLCO icon
109
Melco Resorts & Entertainment
MLCO
$1.92B
$570K 0.29%
64,273
-3,189
-5% -$26K
MDY icon
110
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.1B
$569K 0.29%
1,121
USA icon
111
Liberty All-Star Equity Fund
USA
$1.81B
$566K 0.29%
88,636
+21,648
+32% +$132K
BMY icon
112
Bristol-Myers Squibb
BMY
$130B
$560K 0.28%
10,915
-541
-5% -$28.4K
LIN icon
113
Linde
LIN
$215B
$552K 0.28%
1,344
+21
+2% +$8.28K
BXMT icon
114
Blackstone Mortgage Trust
BXMT
$2.25B
$546K 0.28%
25,650
+5,798
+29% +$125K
MOAT icon
115
VanEck Morningstar Wide Moat ETF
MOAT
$11.7B
$542K 0.27%
6,390
-7,712
-55% -$599K
FDLO icon
116
Fidelity Low Volatility Factor ETF
FDLO
$1.41B
$538K 0.27%
10,149
-37
-0.4% -$1.87K
PFE icon
117
Pfizer
PFE
$158B
$538K 0.27%
18,673
+7,361
+65% +$223K
DVN icon
118
Devon Energy
DVN
$55.3B
$531K 0.27%
11,726
-2,911
-20% -$133K
XIFR
119
XPLR Infrastructure LP
XIFR
$1.08B
$530K 0.27%
17,413
+8,787
+102% +$224K
EFV icon
120
iShares MSCI EAFE Value ETF
EFV
$32B
$527K 0.27%
10,119
+524
+5% +$25.9K
ONEQ icon
121
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.7B
$524K 0.26%
8,853
-7,318
-45% -$401K
GOOD
122
Gladstone Commercial Corp
GOOD
$615M
$523K 0.26%
39,536
-1,808
-4% -$22.6K
GPN icon
123
Global Payments
GPN
$23.4B
$521K 0.26%
+4,103
New +$475K
VIG icon
124
Vanguard Dividend Appreciation ETF
VIG
$112B
$517K 0.26%
3,034
+3
+0.1% +$483
ELV icon
125
Elevance Health
ELV
$90.8B
$512K 0.26%
1,085
+20
+2% +$9.25K

Similar funds

Samalin Investment Counsel's Q4 2023 Portfolio in Review

As of Q4 2023, Samalin Investment Counsel held 284 positions worth $198M, up 14% from $174M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Samalin Investment Counsel deployed $9.01M of net new capital in Q4 2023, opening 27 new positions and adding to 128 existing holdings. Its largest new stake was Vanguard World Funds Extended Duration ETF: 18,427 shares worth $1.49M.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 48% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was VanEck Merk Gold Trust, an estimated $728K trimmed.

  • Samalin Investment Counsel's largest Q4 2023 buy was Vanguard World Funds Extended Duration ETF: 18,427 shares worth $1.49M.
  • Samalin Investment Counsel added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.02M increase.
  • Samalin Investment Counsel's biggest Q4 2023 reduction was VanEck Merk Gold Trust, cutting an estimated $728K.
  • Samalin Investment Counsel fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $1M.
  • Samalin Investment Counsel's ten largest holdings make up 19% of its $198M portfolio in Q4 2023.
  • Samalin Investment Counsel opened 27 new positions and closed 12 in Q4 2023.
  • Samalin Investment Counsel's portfolio value rose 14% quarter-over-quarter to $198M.

Based on Samalin Investment Counsel's 13F filing for Q4 2023, filed 14 Feb 2024.